Analyst Maintains Hold on Microchip as Cyclical Recovery Strengthens but Valuation Caps Upside; Sets $105 Price Target

TD Cowen analyst Joshua Buchalter has maintained their neutral stance on MCHP stock, giving a Hold rating on May 4.

Joshua Buchalter has given his Hold rating due to a combination of factors related to Microchip’s improving fundamentals and its current valuation. He acknowledges that the latest quarter showed broad-based sequential growth above 10%, healthier bookings, and a notable recovery in gross margins as inventory write-downs and underutilization-related charges eased, while end markets and inventory metrics both indicate that the cyclical recovery is gaining traction.

At the same time, he notes that the stock is trading near record levels even though earnings power and free cash flow have not yet returned to peak, and much of the company’s cash generation is still being directed toward debt reduction rather than robust capital returns. Although he views Microchip’s datacenter exposure and PCIe design wins as attractive long-term drivers, he believes those benefits will be outweighed in the near term by the core cyclical business and sees better risk‑reward in peers with stronger valuation support or cleaner capital return stories, leading him to maintain a Hold with a $105 price target.

In another report released on May 4, Morgan Stanley also maintained a Hold rating on the stock with a $92.00 price target.